Getting The Deal Through logo
Getting The Deal Through

Four A&O alumni follow Dagg to Kirkland

Pharma - News – 06 November 2018

Four former members of the life sciences IP team at Allen & Overy have joined the firm’s ex-head of IP litigation Nicola Dagg at Kirkland & Ellis in London.

Davis Polk and McCann Fitzgerald advise Novo Nordisk on Strongbridge drug buy

Pharma - News – 06 November 2018

Lawyers from Davis Polk & Wardwell in the US and McCann Fitzgerald in Ireland have advised Danish pharma company Novo Nordisk on its purchase of the US and Canadian rights to Strongbridge Biopharma’s hormone deficiency drug Macrilen.

UK pharma company charged after baby deaths

Pharma - News – 06 November 2018

UK police have charged drug compounding company ITH Pharma with multiple offences following the deaths of babies who consumed its baby feed at hospitals around the country four years ago.

UK government proposes new law to safeguard healthcare abroad after Brexit

Pharma - News – 30 October 2018

The UK has introduced a bill to protect healthcare for “190,000 expats and 50 million people who travel abroad every year” after Brexit.

Cravath leads J&J acquisition of Japanese cosmetics and skincare company

Pharma - News – 30 October 2018

Lawyers from Cravath Swaine & Moore have advised Johnson & Johnson (J&J) in the preparation of its offer to acquire Japanese cosmetic and skincare company Ci:z Holdings.

Russian lawmakers poised to create “state monopoly” for opium production

Pharma - News – 30 October 2018

The Russian government’s legislative commission has approved a draft bill that would allow the state-controlled cultivation of medical opium in the country.

Follow Getting the Deal Through for the latest updates on law and regulation worldwide

Follow us on LinkedIn